434 related articles for article (PubMed ID: 25535203)
1. Mevalonates restore zoledronic acid-induced osteoclastogenesis inhibition.
Nagaoka Y; Kajiya H; Ozeki S; Ikebe T; Okabe K
J Dent Res; 2015 Apr; 94(4):594-601. PubMed ID: 25535203
[TBL] [Abstract][Full Text] [Related]
2. Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis.
Kimachi K; Kajiya H; Nakayama S; Ikebe T; Okabe K
Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar; 383(3):297-308. PubMed ID: 21225243
[TBL] [Abstract][Full Text] [Related]
3. Independent pathways in the modulation of osteoclastic resorption by intermediates of the mevalonate biosynthetic pathway: the role of the retinoic acid receptor.
van Beek E; Löwik C; Karperien M; Papapoulos S
Bone; 2006 Feb; 38(2):167-71. PubMed ID: 16165408
[TBL] [Abstract][Full Text] [Related]
4. Zoledronic acid and geranylgeraniol regulate cellular behaviour and angiogenic gene expression in human gingival fibroblasts.
Zafar S; Coates DE; Cullinan MP; Drummond BK; Milne T; Seymour GJ
J Oral Pathol Med; 2014 Oct; 43(9):711-21. PubMed ID: 24762323
[TBL] [Abstract][Full Text] [Related]
5. OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice.
de Molon RS; Shimamoto H; Bezouglaia O; Pirih FQ; Dry SM; Kostenuik P; Boyce RW; Dwyer D; Aghaloo TL; Tetradis S
J Bone Miner Res; 2015 Sep; 30(9):1627-40. PubMed ID: 25727550
[TBL] [Abstract][Full Text] [Related]
6. Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.
Ersan N; van Ruijven LJ; Bronckers AL; Olgaç V; Ilgüy D; Everts V
Dentomaxillofac Radiol; 2014; 43(1):20130144. PubMed ID: 24170800
[TBL] [Abstract][Full Text] [Related]
7. Bone-site-specific responses to zoledronic acid.
Vermeer J; Renders G; van Duin MA; Jansen I; Bakker LF; Kroon SA; de Vries TJ; Everts V
Oral Dis; 2017 Jan; 23(1):126-133. PubMed ID: 27706930
[TBL] [Abstract][Full Text] [Related]
8. Severe compromise of preosteoblasts in a surgical mouse model of bisphosphonate-associated osteonecrosis of the jaw.
Córdova LA; Guilbaud F; Amiaud J; Battaglia S; Charrier C; Lezot F; Piot B; Redini F; Heymann D
J Craniomaxillofac Surg; 2016 Sep; 44(9):1387-94. PubMed ID: 27519659
[TBL] [Abstract][Full Text] [Related]
9. Gymnasterkoreayne F inhibits osteoclast formation by suppressing NFATc1 and DC-STAMP expression.
Kim HJ; Hong J; Jung JW; Kim TH; Kim JA; Kim YH; Kim SY
Int Immunopharmacol; 2010 Nov; 10(11):1440-7. PubMed ID: 20831919
[TBL] [Abstract][Full Text] [Related]
10. Saliva suppresses osteoclastogenesis in murine bone marrow cultures.
Caballé-Serrano J; Cvikl B; Bosshardt DD; Buser D; Lussi A; Gruber R
J Dent Res; 2015 Jan; 94(1):192-200. PubMed ID: 25297116
[TBL] [Abstract][Full Text] [Related]
11. Effect of the release from mechanical stress on osteoclastogenesis in RAW264.7 cells.
Shibata K; Yoshimura Y; Kikuiri T; Hasegawa T; Taniguchi Y; Deyama Y; Suzuki K; Iida J
Int J Mol Med; 2011 Jul; 28(1):73-9. PubMed ID: 21491081
[TBL] [Abstract][Full Text] [Related]
12. F-spondin inhibits differentiation of clastic precursors via lipoprotein receptor-related protein 8 (LRP8).
Oka H; Kitagawa M; Takata T
J Periodontol; 2015 Mar; 86(3):465-72. PubMed ID: 25299387
[TBL] [Abstract][Full Text] [Related]
13. Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice.
Kobayashi Y; Hiraga T; Ueda A; Wang L; Matsumoto-Nakano M; Hata K; Yatani H; Yoneda T
J Bone Miner Metab; 2010 Mar; 28(2):165-75. PubMed ID: 19882100
[TBL] [Abstract][Full Text] [Related]
14. Establishment of an Animal Model of Bisphosphonate-Related Osteonecrosis of the Jaws in Spontaneously Diabetic Torii Rats.
Takaoka K; Yamamura M; Nishioka T; Abe T; Tamaoka J; Segawa E; Shinohara M; Ueda H; Kishimoto H; Urade M
PLoS One; 2015; 10(12):e0144355. PubMed ID: 26659123
[TBL] [Abstract][Full Text] [Related]
15. The effect of etidronate on the periodontium of ovariectomized rats.
Said F; Ghoul-Mazgar S; Khemiss F; El Ayeb H; Saidane D; Berdal A; Ruhin-Poncet B
J Periodontol; 2012 Aug; 83(8):1063-8. PubMed ID: 22166164
[TBL] [Abstract][Full Text] [Related]
16. Oral malodorous compound induces osteoclast differentiation without receptor activator of nuclear factor κB ligand.
Ii H; Imai T; Yaegaki K; Irie K; Ekuni D; Morita M
J Periodontol; 2010 Nov; 81(11):1691-7. PubMed ID: 20583917
[TBL] [Abstract][Full Text] [Related]
17. The effects of bisphosphonate on the remodeling of different irregular bones in mice.
Su J; Feng M; Han W; Zhao H
J Oral Pathol Med; 2015 Sep; 44(8):638-48. PubMed ID: 25370709
[TBL] [Abstract][Full Text] [Related]
18. Zoledronic Acid Deteriorates Soft and Hard Tissue Healing of Murine Tooth Extraction Sockets in a Dose-Dependent Manner.
Kozutsumi R; Kuroshima S; Kaneko H; Sasaki M; Ishisaki A; Sawase T
Calcif Tissue Int; 2022 Jan; 110(1):104-116. PubMed ID: 34363509
[TBL] [Abstract][Full Text] [Related]
19. Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
Gross C; Weber M; Creutzburg K; Möbius P; Preidl R; Amann K; Wehrhan F
J Transl Med; 2017 Jun; 15(1):128. PubMed ID: 28587628
[TBL] [Abstract][Full Text] [Related]
20. Exposing human epithelial cells to zoledronic acid can mediate osteonecrosis of jaw: an in vitro model.
Saracino S; Canuto RA; Maggiora M; Oraldi M; Scoletta M; Ciuffreda L; Vandone AM; Carossa S; Mozzati M; Muzio G
J Oral Pathol Med; 2012 Nov; 41(10):788-92. PubMed ID: 22650360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
